Dataset Information

Iridovirus and Microsporidian Linked to Honey Bee Colony Decline

ABSTRACT: this is the raw data accompanying the following publication: Bromenshenk JJ, Henderson CB, Wick CH, Stanford MF, Zulich AW, Jabbour RE, Deshpande SV, McCubbin PE, Seccomb RA, Welch PM, Williams T, Firth DR, Skowronski E, Lehmann MM, Bilimoria SL, Gress J, Wanner KW, Cramer RA Jr. Iridovirus and microsporidian linked to honey bee colony decline. PLoS One. 2010 Oct 6;5(10):e13181. doi: 10.1371/journal.pone.0013181. PubMed PMID: 20949138; PubMed Central PMCID: PMC2950847.

INSTRUMENT(S): LTQ

SUBMITTER: Cramer, Robert A.

PROVIDER: MSV000078942 | MassIVE | Wed Nov 19 10:07:00 GMT 2014

SECONDARY ACCESSION(S): PXD001517

REPOSITORIES: MassIVE

ACCESS DATA

Publications

Iridovirus and microsporidian linked to honey bee colony decline.

Bromenshenk Jerry J JJ Henderson Colin B CB Wick Charles H CH Stanford Michael F MF Zulich Alan W AW Jabbour Rabih E RE Deshpande Samir V SV McCubbin Patrick E PE Seccomb Robert A RA Welch Phillip M PM Williams Trevor T Firth David R DR Skowronski Evan E Lehmann Margaret M MM Bilimoria Shan L SL Gress Joanna J Wanner Kevin W KW Cramer Robert A RA

PloS one 20101006 10

In 2010 Colony Collapse Disorder (CCD), again devastated honey bee colonies in the USA, indicating that the problem is neither diminishing nor has it been resolved. Many CCD investigations, using sensitive genome-based methods, have found small RNA bee viruses and the microsporidia, Nosema apis and N. ceranae in healthy and collapsing colonies alike with no single pathogen firmly linked to honey bee losses.We used Mass spectrometry-based proteomics (MSP) to identify and quantify thousands of pro ...[more]

PMID: 20949138

Similar Datasets

Project description:HLA-DR molecules are highly expressed in synovial tissue (ST), the target of the immune response in chronic inflammatory arthritides, including in rheumatoid arthritis (RA) and Lyme arthritis (LA). In the current study, we identified HLA-DR-presented self-peptides (T cell epitopes) in ST, synovial fluid mononuclear cells (SF), and peripheral blood mononuclear cells (PB) from five patients with RA and eight with LA. Altogether, from 22 samples, 1,532 non-redundant HLA-DR-presented peptides were identified that were derived from 778 source proteins. Moreover, as the study progressed, application of newer, high sensitivity LC-MS instruments resulted in the identification of larger numbers of HLA-DR-presented peptides. Surprisingly, the source proteins for HLA-DR-presented peptides were as likely to have intracellular as extracellular locations. Although the number of peptides identified was greater in ST than in SF or PB, 68% of the peptides identified in SF were found in ST, and 55% of the peptides in PB were found in ST. Two RA patients had the same HLA-DR genotype (DRB1*0401 and 0101), and 44% of the peptides identified in these two patients were the same. In contrast, among the patients with RA or LA who had no shared HLA-DR alleles, only 6% of the peptides were the same. In the RA patients, HLA-DR-presented peptides were identified from source proteins that are thought to serve as potential autoantigens: collagen, enolase, fibrinogen, fibronectin, immunoglobulin and vimentin. Interestingly, peptides from these same source proteins were also commonly found in LA patients. However, citrullinated T cell epitopes were not identified in any patient. Thus, LC-MS/MS techniques are now sensitive enough to identify large numbers of T cell epitopes from tissue or fluids in individual patients. Importantly, analysis of SF or PB allowed us to identify a broader range of HLA-DR-presented self-peptides from individual patients and from patients seen earlier in the disease.